Since we measured elevated ADAM17 levels in patients suffering from ovarian cancer, we proceeded with investigating whether ADAM17 levels correlate with other clinical parameters, such as the FIGO stage, histological subtype, or the postoperative resection status. Here, ADAM17 is linked to ovarian cancer.